New guidelines on hypertension management in primary care have been released, offering updated recommendations to improve the diagnosis and treatment of high blood pressure. These guidelines, focusing on family physicians and other primary care clinicians, emphasize lower blood pressure targets, a key change designed to enhance patient outcomes. Early detection and intervention are at the forefront of these updates, aiming to mitigate long-term cardiovascular complications.The new guidelines adopt the World Health Institution’s HEARTS framework, proven to boost hypertension control rates. The guideline committee considered efficacy, tolerability, and cost when recommending treatments for both standard and tough-to-treat cases. Read more from News Directory 3 as the first of two guidelines rolls out to better serve the community. Discover what’s next as a second,in-depth guide is released to further support clinicians.
New Hypertension Guideline Aims to Improve Primary Care
A new Hypertension Canada guideline published in the Canadian Medical Association Journal offers updated recommendations for diagnosing and treating hypertension, targeting primary care clinicians such as family physicians, nurses, nurse practitioners, and pharmacists. the guideline seeks to improve the management of high blood pressure,a meaningful risk factor for heart disease and mortality.
While Canada has historically led in hypertension treatment, recent years have seen a decline in success rates. Discrepancies in blood pressure targets and complex recommendations may contribute to this trend.
dr. Ross Tsuyuki, past president of Hypertension Canada, emphasized the importance of primary care in managing hypertension. He stated that supporting primary care practitioners will enhance hypertension care and benefit Canadians.
The guideline adopts the World Health Institution’s (WHO) HEARTS framework, which has proven prosperous in improving cardiovascular health globally. In one U.S.location,it boosted hypertension control rates from 44% to 90% in just over a decade.
Based on current evidence, the guideline provides recommendations for assessing blood pressure, defining hypertension, promoting healthy lifestyle changes, and using pharmacotherapy for treatment, including tough-to-treat cases.
The guideline committee considered efficacy, tolerability, cost, coverage, availability, and potential for drug shortages when selecting medications.
A key change involves lower blood pressure thresholds for defining hypertension and setting treatment targets.
Dr. Greg Hundemer, guideline co-chair, acknowledged that the lower thresholds might lead to more peopel being diagnosed wiht hypertension, potentially affecting insurance coverage and causing stigma. However, the committee believes that early detection and intervention will mitigate long-term cardiovascular complications.
The guideline was developed by a committee of family physicians,pharmacists,a nurse practitioner,hypertension specialists,and a methodologist. Four patient partners also contributed feedback and helped create a patient support tool.
This is the first of two guidelines, with the second addressing more complex aspects of hypertension management.
Dr.Rémi Goupil, guideline co-chair, clarified that this guideline is not intended for all clinical scenarios, such as managing hypertension in children or pregnant individuals. Separate guidelines exist for those populations. The new guideline aims to cover approximately 95% of uncomplicated hypertension cases in the community and complements the upcoming comprehensive guideline.
“As primary care is where most hypertension is managed, supporting primary care practitioners to better diagnose and manage this disease will improve hypertension care at the population level and benefit people in Canada.”
“The lower BP thresholds adopted for both defining hypertension and treatment targets relative to previous Hypertension Canada guidelines means that more people will be labeled as having hypertension, which may have meaningful personal implications, like stigma, insurance coverage and more.”
“This guideline is not intended to be applied in all clinical scenarios, such as managing hypertension in children or in people who are pregnant or trying to become pregnant. Separate guidelines are available for these patient populations.”
What’s next
The second guideline, focusing on complex hypertension management, is expected to be released soon, offering further support for clinicians managing challenging cases.
